Tang Capital Management LLC Alx Oncology Holdings Inc Call Options Transaction History
Tang Capital Management LLC
- $1.67 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALXO
# of Institutions
68Shares Held
31.6MCall Options Held
53.8KPut Options Held
11.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$6.01 Million4.29% of portfolio
-
Redmile Group, LLC San Francisco, CA3.39MShares$2.1 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.67 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.54MShares$1.57 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$992,5000.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $25.3M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...